Support MS Research

Sign Up to eNewsletter

Be the first to receive the latest news on MS Research.

 

News

Showing 1 to 10 of 816

World-first blood test to aid prognosis and treatment of MS

3rd February, 2017

MS Research Australia-supported researchers at Macquarie University have developed a potential blood test that will help differentiate between the three subtypes of MS

Read More

Anxiety levels may affect thinking abilities in MS

1st February, 2017

Researchers from Newcastle, NSW, have shown that anxiety and cognitive problems can go hand-in-hand in MS, suggesting that treating anxiety could improve thinking

Read More

Research into lifestyle benefits for people with MS

23rd January, 2017

There is a great deal of interest in the MS community and reported in the media about the influence of lifestyle factors affecting MS disease course and outcomes

Read More

MS Research Australia 2017 grant successes announced

19th January, 2017

MS Research Australia is delighted to announce a further $1.5 million in research funding for grants commencing in January 2017. The grants cover a range of scientific and allied health disciplines to

Read More

$1 million worth of pro-bono support

19th January, 2017

Pro bono support is crucial to the success of MS Research Australia. It ensures the organisational and fundraising expenses are kept as low as possible, maximising the amount of funding invested into

Read More

International attention focussed on progressive MS

11th January, 2017

One of the core goals of the International Progressive MS Alliance is to not only bring together researchers and fund research into progressive MS, but also to focus the attention and efforts of the

Read More

Full trial results released for new progressive MS treatment ocrelizumab

10th January, 2017

Full clinical trial results for ocrelizumab, a new treatment for primary progressive and relapsing MS have been formally published

Read More

Zinbryta has been recommended for inclusion on the PBS

20th December, 2016

Zinbryta (daclizumab) has been recommended for inclusion on the Pharmaceutical Benefits Scheme by the PBAC at their November meeting

Read More

Ageing myelin, the cause of MS?

8th December, 2016

Researchers at the University of Wollongong have found an interesting phenomena when myelin ages which may be a contributing factor in the development of MS.

Read More

Priorities for research – listening to the MS community

7th December, 2016

Earlier this year we asked the Australian MS community, to let us know your thoughts on the priorities for the many different areas of MS research

Read More

Showing 1 to 10 of 816